Objectives: To examine patterns of prescribing of oral antibiotics during pregnancy and to determine whether women were more or less likely to receive specific types of antibiotics in pregnancy than in the years before and after pregnancy. Finally, to identify socio-demographic factors associated with antibiotic prescribing in pregnancy.
Introduction
Oral antibiotics are among the most frequently prescribed medicines in primary care and most oral antibiotics are considered safe for use in pregnancy. There is clear evidence from randomized controlled trials for maternal and fetal benefits of treatment in pregnancy for symptomatic bacterial infections, 1,2 and prophylactic treatment for women with asymptomatic bacteriuria, 3 preterm rupture of the membranes 4 or colonization with group B streptococci. 5 However, evidence is emerging of potential adverse effects of antibiotics in pregnancy. Recent findings from a large randomized controlled trial showed an increased risk of cerebral palsy in preterm babies followed up to age 7 years, who were born to women treated with antibiotics compared with placebo. 6 Other studies have shown an increase in the rate of early onset Gram-negative bacteraemia in newborns with low birth weight, or an increase in the prevalence of resistant organisms in the maternal gut flora associated with prenatal antibiotics. These patterns may have consequences for mother, baby and the wider community. 7 -10 Despite these concerns, the evidence about prescribing of antibiotics in pregnancy is limited, although patterns appear to vary between countries (Table 1) . Only one study from Germany reported prescribing of different classes of antibiotics throughout pregnancy. 11 The aim of this study was to examine patterns of prescribing of oral antibiotics during pregnancy, and how these have changed over time, in UK primary care using a large primary care research database, The Health Improvement Network (THIN). We determined whether women were more or less likely to receive specific types of antibiotics in pregnancy than in other periods of their lives using the self-controlled case series (SCCS) methodology.
Methods

Study participants: pregnant cohort
We identified 114999 women who gave live birth between 1992 and 2007 in the primary care database THIN (http://www.epic-uk.org/thin. htm). It is one of the largest UK sources of continuous anonymized primary care data including records (Read codes) of all encounters between patients and clinicians. Practices contributing to the database are broadly representative of UK general practices in terms of patients' age and sex, practice size and geographical distribution. 12 General practitioners (GPs) enter clinical data from each consultation and the database includes demographic information (i.e. age, sex and estimates of deprivation using quintiles of Townsend scores based on the individual's residential location) and clinical data (i.e. medical diagnosis and symptom records, health promotion activity, referrals to secondary care and prescriptions). In contrast to some administrative databases and insurance claim databases, UK primary care databases do not hold information about prescriptions issued in secondary care.
We included women who were registered with a general practice at least 6 months before they became pregnant and were still registered with the practice when the child was delivered. Within this cohort we identified two subcohorts which were registered at least a year before or a year after the pregnancy. These cohorts were used when comparisons were made within individual women to non-pregnant periods. For women with more than one pregnancy, we randomly selected one pregnancy for analysis. The duration of pregnancy was estimated to be 280 days (40 weeks) unless more detailed information was available on gestational age of the baby at birth, preterm birth or date of last menstrual period. Pregnancy trimesters were defined from the first day of the last menstrual period to 14 weeks and 6 days (first trimester); 15-27 weeks and 6 days (second trimester); and 28 weeks to delivery (third trimester).
Antibiotics
Oral antibiotics were categorized according to the British National Formulary (BNF) 54 (September 2007). We performed separate analyses for the following types of antibiotics: benzylpenicillin and phenoxymethylpenicillin; penicillinase-resistant penicillins; broad-spectrum penicillins (amoxicillin, ampicillin, co-amoxiclav and co-fluampicil); cephalosporins and other b-lactams; tetracyclines*; macrolides; sulphonamides and trimethoprim*; metronidazole* and tinidazole; quinolones*; and antibiotics used specifically for urinary tract infections. The remaining antibiotics were rarely prescribed during pregnancy. We also identified drugs with a caution or contraindication in pregnancy (marked with * above). This was based on the information provided in the BNF under each individual drug or in BNF Appendix 4.
Indications for prescribing
The database does not hold a direct link between antibiotic prescriptions and indication. However, we searched the medical records for a potential indication entered in the clinical records for each entry made of a prescription of an antibiotic in pregnancy and in an equivalent period a year before. When there were multiple antibiotics prescribed on the same date it was not possible to distinguish the indications and these prescriptions were excluded [542 prescriptions (less than 1%)].
Data analyses
The prevalence of antibiotic prescribing during pregnancy was estimated for each calendar year between 1992 and 2007 and numbers of prescriptions for individual drug classes were tabulated for each period of 4 weeks and for each trimester of the pregnancy. Poisson regression was used to examine whether maternal age and social deprivation (Townsend scores) were associated with increased antibiotic prescribing during pregnancy.
To compare antibiotic prescribing during pregnancy with periods before and after pregnancy we used the SCCS methodology. 13 For each woman, we considered the period when she was pregnant as the 'exposed' period and counted the number of prescriptions within this period. Two separate 'unexposed' periods of equal length to the pregnancy were identified. The first period began 1 year before the start of the pregnancy and the second period began 1 year after the start of pregnancy. By choosing these periods to start exactly a year before and after pregnancy start we took into account the seasonality in prescribing of antibiotics. Women were included in the analyses if they had one or more antibiotics prescribed in any of the exposed or unexposed periods. For this part of the study, women were excluded if they were pregnant in the years before or after pregnancy or were not registered with the general practice for the period when the comparisons were made. For these analyses, we considered prescribing 'episodes', i.e. if a woman received more than one prescription of the same drug within 14 days we counted these as the same episode. First, we analysed the data including all antibiotic prescriptions. Second, we examined separate classes of antibiotics.
The study was approved by the Cambridgeshire 4 Research Ethics Committee (08/H0305/33). The study was also reviewed by the primary care database steering committee within the Department of Primary Care and Population Health, UCL.
Results
Overall, 114999 pregnant women were included in the study. The median age at delivery was 30.5 years (interquartile range 26 -34 years). A third of these women (37 468) received at least one antibiotic prescription during the pregnancy. The majority (65%) of these received just one prescription (24 298). In total 59 260 prescriptions were issued. Broad-spectrum penicillins were most commonly prescribed (48% of all prescriptions), followed by cephalosporins and other b-lactams (22%), benzylpenicillin and phenoxymethylpenicillin (7%), macrolides (7%) and penicillinase-resistant penicillins (5%). Erythromycin constituted the majority of the macrolides, whilst amoxicillin constituted the majority of broad-spectrum penicillins. Co-amoxiclav accounted for 8% of the broad-spectrum penicillin prescriptions. In any trimester of pregnancy, 14% of women received at least one antibiotic prescription and between 4% and 5% received an antibiotic in any 4 week period up to 40 weeks of gestation ( Table 2) . Prescription of broad-spectrum penicillins and cephalosporins increased in the first 16 weeks, but remained at the same level thereafter ( Table 2 ). The prescription of antibiotics which are cautioned or contraindicated in pregnancy (i.e.
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SCCS analysis
Fewer antibiotics were prescribed during pregnancy compared with similar periods before {pregnancy versus before: incidence rate ratio for all antibiotics (IRR) 0.91 [95% confidence interval (CI) 0.90 -0.93], P, 0.001, n¼ 35102} or after [pregnancy versus after: IRR 0.98 (95% CI 0.96 -0.99), P ¼ 0.004, n¼ 34683]. Antibiotics that were contraindicated or cautioned during pregnancy were prescribed less often in pregnancy than during a similar period before pregnancy ( Figure 1 ). The same was true of benzylpenicillins and phenoxymethylpenicillins, macrolides and (Figure 1) .
In terms of absolute differences, the largest difference was observed for broad-spectrum penicillins, which accounted for 313/1000 antibiotic prescriptions before pregnancy and 481/1000 prescriptions during pregnancy, followed by cephalosporins (90/1000 before versus 219/1000 prescriptions during pregnancy) ( Table 3 ). The absolute difference was less marked for antibiotics prescribed specifically for urinary tract infections (nitrofurantoin) (9/1000 before versus 23/1000 prescriptions during pregnancy).
Indications for prescribing
Respiratory, urinary, skin and ear infections were the most frequently recorded indications for antibiotic prescribing both before and during pregnancy. Overall, indication for urinary tract infection was higher in pregnancy than in an equivalent period a year before. On the other hand, substantially fewer records were indicative of respiratory, skin and ear infections during than before pregnancy (Table 3 ). The change of indication was particular noticeable for broad-spectrum antibiotics and cephalosporins, with a rise in urinary indications and a decline in respiratory, skin and ear infections during pregnancy. Furthermore, substantially fewer indications of respiratory infections were made for benzylpenicillin and phenoxymethylpenicillin during pregnancy. However, large proportions of all antibiotics were prescribed without an indication recorded (Table 3) .
For a few prescriptions there was more than one potential indication. For example, 737 prescriptions issued in pregnancy were linked to codes for a respiratory tract and ear infection.
Time trends
The proportion of women receiving antibiotics during pregnancy increased from 29% in 1992 to 38% in 1997. It then declined to 30% in 2002-03, but has been on the increase in recent years. In 2007, 34% of women received at least one prescription for antibiotics during pregnancy. These changes were mainly driven by a change in prescription of broad-spectrum penicillins (Figure 2 ). Prescribing of cephalosporins has also increased substantially from 5% of pregnant women in 1992 to 10% in 2007 (Figure 2 ). The level of prescribing of antibiotics that are contraindicated or cautioned for use in pregnancy remained unchanged throughout this period.
Demographic factors for prescribing
Younger women were most likely to be prescribed antibiotics during pregnancy; 41% of women aged 13 -19 years were prescribed antibiotics compared with 29-30% in women over 30 years old (Table 4 ). The unadjusted incidence risk ratio for women aged 13 -19 years (compared with women over 40 years old) was 1.42 (95% CI 1.33-1.52), and 1.33 (95% CI 1.24-1.42) after adjustment for deprivation (Table 4) . Women living in deprived areas were more likely to be prescribed antibiotics during pregnancy (39% in the most deprived quintile versus 29% in the least deprived quintile). The effect of deprivation was partly confounded by age as shown by the change in the incidence risk ratio for antibiotic prescribing in the most deprived compared with the least deprived quintile from 1.35 (95% CI 1.31-1.40) before adjustment to 1.29 (95% CI 1.21-1.30) after adjustment for age (Table 4) .
Discussion
A third of pregnant women received one or more antibiotic prescriptions during pregnancy and in any trimester 14% received a prescription. Overall antibiotic prescribing in pregnancy was marginally lower than 1 year earlier. However, broad-spectrum penicillins, cephalosporins and antibiotics for urinary tract infections were prescribed more frequently in pregnancy. In recent years, antibiotic prescribing in pregnancy has been increasing mainly due to increased use of broad-spectrum penicillins and a doubling in the prescribing of cephalosporins.
To our knowledge this is the first UK study to examine oral antibiotic prescribing in primary care during pregnancy in detail. A crude comparison with data from other countries suggests that prescribing during pregnancy is lower in the UK than in France   14 and the USA, 15 but higher than in Germany, 11, 16 Finland, 17 the Netherlands 18 and Norway 19 (Table 1) . These comparisons between studies need to be interpreted with caution. Firstly, data sources vary. Some include prescribing only in primary care (as in this study) and thus provide a minimum estimate of what is prescribed during pregnancy, whereas others include both primary and secondary care. Secondly, the definition of antibiotic prescription varied between studies. Some studies used a broad definition (anti-infectives 15, 16 ) whereas others have used a more specific definition [systemic antibiotics (ATC J01) 11 ]. Thirdly, prescription data could overestimate the actual usage as compliance in pregnancy may be low due to fear of adverse effects on the fetus. 20 On the other hand, studies based on maternal self-report (ALSPAC) 21 are likely to underestimate usage as the mother may forget to report use several weeks before she fills in the questionnaires.
Our findings relating to the effect of young maternal age and deprivation are consistent with previous studies. Amann et al.
11
reported that being younger than 21 years [adjusted odds ratio 2.14 (1.80 -2.53)] or being a welfare recipient [adjusted odds ratio 1.57 (1.25 -2.00)] was associated with higher antibiotic usage during pregnancy. Similar patterns of antibiotic prescribing have been observed in the general population. 22, 23 Bakker et al. 18 only found a slight reduction in overall systemic antibiotic prescription in the first trimester of pregnancy. On the other hand, Amann et al.
11 did find a noticeable overall reduction in antibiotic prescribing during pregnancy. Our results and those of Amann et al.
11 also showed overall changes in the types of antibiotics prescribed in pregnancy, with a decrease in prescribing of most antibiotics in pregnancy except for broad-spectrum antibiotics and cephalosporins. This implies these antibiotics were considered to be the safest option in pregnancy.
We know that broad-spectrum antibiotics drive antibiotic resistance and pathogen selection, but know very little about their effect on maternal vaginal flora, and the consequences for pregnancy outcome and for infant gut flora. Emerging 
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Antibiotic prescribing in pregnancy 2243 JAC evidence suggests potential adverse effects and indicates the need for further research. Firstly, lactobacilli that predominate in the vaginal flora are highly susceptible to broad-spectrum antibiotics. Low levels of peroxidase-producing lactobacilli at 20 weeks of pregnancy may be associated with an increased risk of preterm delivery. 24 Whether there are further consequences for pathogen selection is not known. Secondly, the maternal vaginal flora has an influence on the gut flora of the newborn, and there is strong evidence that early gut colonizers are likely to persist. 25 The implication is that maternal antibiotics Petersen et al.
could affect the heterogeneity of newborn gut flora and colonization by certain pathogens or resistant bacteria.
Indications for antibiotic prescribing during pregnancy differed in comparison with an equivalent period before pregnancy. In particular, we observed an increase in antibiotic prescribing of broad-spectrum penicillins and cephalosporins for urinary tract infections and a decrease in antibiotics for respiratory, skin and ear infections. These changes may be due to a combination of factors: (i) the rate of some infections during pregnancy differs from before pregnancy; (ii) urinary tract infections were more likely to be detected in pregnancy; (iii) thresholds for treatment differ; and (iv) GP recording of indications may differ for women who are pregnant. Interpretation of these changes should be made with caution as a large proportion of antibiotics were prescribed without an indication recorded (438/1000 in pregnancy and 389/1000 before). There may be scope for further reduction of antibiotic prescribing for respiratory infections in pregnancy. However, it is important that this is balanced against potential risk and benefits for both mother and child.
Conclusions
Antibiotic prescribing is widespread in pregnancy, although marginally reduced compared with a year earlier. There were substantial changes in types of antibiotics as well as in their indications during pregnancy. This may be explained by changes in threshold for treatment, diseases, detection and recording. Younger women and women from deprived areas were most likely to receive antibiotics in pregnancy. Antibiotic prescribing in pregnancy
